Andy Haigh, the President and CEO of Adapsyn Bioscience, joins the "Conversations" podcast to talk about antimicrobial resistance. A Hamilton-based chemical bioinformatics company, Adapsyn is a world leader in the discovery and development of novel bacterial metabolites for use as therapeutics.
Conversations Podcast – Antibiotic Awareness with Andy Haigh (Ep. 03)
Updated: Dec 17, 2020